| 缩写名/全名 |
EXPERT OPIN THER TAR
EXPERT OPINION ON THERAPEUTIC TARGETS |
||||||||||||||||||||||||||||
| ISSN号 | 1472-8222 | ||||||||||||||||||||||||||||
| 研究方向 | 医学-药学 | ||||||||||||||||||||||||||||
| 影响因子 | 2015:4.798, 2016:4.873, 2017:4.598, 2018:4.621, 2019:5.473, | ||||||||||||||||||||||||||||
| 出版国家 | ENGLAND | ||||||||||||||||||||||||||||
| 出版周期 | Monthly | ||||||||||||||||||||||||||||
| 年文章数 | 65 | ||||||||||||||||||||||||||||
| 出版年份 | 2001 | ||||||||||||||||||||||||||||
| 是否OA | No | ||||||||||||||||||||||||||||
| 审稿周期(仅供参考) | 偏慢,4-8周 |
||||||||||||||||||||||||||||
| 录用比例 | 一般 | ||||||||||||||||||||||||||||
| 投稿链接 | https://mc.manuscriptcentral.com/eott | ||||||||||||||||||||||||||||
| 投稿官网 | http://www.tandfonline.com/loi/iett20#.V48c20z9cSQ | ||||||||||||||||||||||||||||
| h-index | 78 | ||||||||||||||||||||||||||||
| CiteScore |
|
||||||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1472-8222%5BISSN%5D | ||||||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2018年新版本） |
|
||||||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年新版本） |
|
| 中国学者近期发表的论文 | |
| 1. | Targeting the cell signaling pathway Keap1-Nrf2 as a therapeutic strategy for adenocarcinomas of the lung. Author: Zhang B1,2, Ma Z1, Tan B1, Lin N1,2. Journal: Expert Opin Ther Targets. 2019 Mar;23(3):241-250. doi: 10.1080/14728222.2019.1559824. Epub 2018 Dec 27. PubMed DOI |
| 2. | The P2X7 receptor: a new therapeutic target in Alzheimer's disease. Author: Illes P1,2, Rubini P2, Huang L2, Tang Y2. Journal: Expert Opin Ther Targets. 2019 Mar;23(3):165-176. doi: 10.1080/14728222.2019.1575811. PubMed DOI |
| 3. | Pro-resolving lipid mediators as therapeutic leads for cardiovascular diseases. Author: Cheng Y1, Rong J2. Journal: Expert Opin Ther Targets. 2019 May;23(5):423-436. doi: 10.1080/14728222.2019.1599360. Epub 2019 Apr 1. PubMed DOI |
| 4. | TANK-binding kinase 1 as a novel therapeutic target for viral diseases. Author: Zhao C1,2,3, Zhao W1,2,3. Journal: Expert Opin Ther Targets. 2019 May;23(5):437-446. doi: 10.1080/14728222.2019.1601702. Epub 2019 Apr 10. PubMed DOI |
| 5. | TIPE2 as a potential therapeutic target in chronic viral hepatitis. Author: Ji J1, Zhang YY2, Fan YC3,4. Journal: Expert Opin Ther Targets. 2019 Jun;23(6):485-493. doi: 10.1080/14728222.2019.1608948. Epub 2019 Apr 22. PubMed DOI |
| 6. | Are Th17 cells and their cytokines a therapeutic target in Guillain-Barré syndrome? Author: Wu X, Wang J, Liu K, Zhu J, Zhang HL. Journal: Expert Opin Ther Targets. 2016;20(2):209-22. doi: 10.1517/14728222.2016.1086751. Epub 2015 Sep 10. PubMed |
| 7. | Serum uric acid: a new therapeutic target for nonalcoholic fatty liver disease. Author: Sun DQ, Wu SJ, Liu WY, Lu QD, Zhu GQ, Shi KQ, Braddock M, Song D, Zheng MH. Journal: Expert Opin Ther Targets. 2016;20(3):375-87. doi: 10.1517/14728222.2016.1096930. Epub 2015 Sep 30. PubMed |
| 8. | The diverse oncogenic and tumor suppressor roles of salt-inducible kinase (SIK) in cancer. Author: Du WQ, Zheng JN, Pei DS. Journal: Expert Opin Ther Targets. 2016;20(4):477-85. doi: 10.1517/14728222.2016.1101452. Epub 2015 Nov 7. PubMed |
| 9. | Therapeutic implications of innate immune system in acute pancreatitis. Author: Shamoon M, Deng Y, Chen YQ, Bhatia M, Sun J. Journal: Expert Opin Ther Targets. 2016;20(1):73-87. doi: 10.1517/14728222.2015.1077227. Epub 2015 Nov 13. PubMed |
| 10. | Role of AMPK signaling in mediating the anticancer effects of silibinin in esophageal squamous cell carcinoma. Author: Li J, Li B, Xu WW, Chan KW, Guan XY, Qin YR, Lee NP, Chan KT, Law S, Tsao SW, Cheung AL. Journal: Expert Opin Ther Targets. 2016;20(1):7-18. doi: 10.1517/14728222.2016.1121236. Epub 2015 Dec 15. PubMed |
|
|
